Replies to post #118490 on NorthWest Biotherapeutics Inc (NWBO)

[DownWithPumpers]

The average patient has progression after 1.7 months.

Nobody was allowed in the trial who had progression after two months.

Right from the beginning it is trivial to see that the sickest 50% of patients weren't allowed in the trial.

Now we just have to figure out if not allowing them in has any affect on how long the group is likely to survive. That's something to ponder.